The Nutshell

» NIH and cancer

Daily News Roundup

Most Recent

image: Distinguishing Circulating Tumor from Normal Cell-Free DNA

Distinguishing Circulating Tumor from Normal Cell-Free DNA

By | July 19, 2016

Fragments of circulating DNA from tumors are around 20 to 30 base pairs shorter than those from healthy cells, researchers report.

0 Comments

Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.

0 Comments

image: CRISPR Combats Herpes

CRISPR Combats Herpes

By | July 5, 2016

Scientists use the gene editing technology to target active and latent virus in mammalian cell cultures.

0 Comments

Human cancer cells constrained to capillary-like microtubes divide unevenly, scientists show.

0 Comments

image: Treating Cancer with CRISPR?

Treating Cancer with CRISPR?

By | June 17, 2016

A federal panel will review the first proposal for the use of the technology to edit human genes for medical purposes.

0 Comments

image: TS Picks: June 6, 2016

TS Picks: June 6, 2016

By | June 6, 2016

American Society of Clinical Oncology meeting edition 

0 Comments

Exposing male rats to nonionizing radiation increased the animals’ risk of brain and heart tumors in a study, but the findings are far from conclusive.

0 Comments

A Congressional investigation indicates that the National Football League may have sought to steer millions of dollars in National Institutes of Health funding away from one of its critics.

0 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

The Oracle cofounder’s gift will fund a new institute at the University of Southern California.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech